Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.


Lawmaker wants pharmacists to be able to disclose price of a drug

DATE: April 25, 2018

Published by WILX 10

LANSING, Mich. (AP) – A Michigan lawmaker wants to give pharmacists the right to disclose the actual price they paid for a drug.

Republican state Rep. Mary Whiteford of Casco Township introduced the drug transparency bill in the state House Tuesday.

An analysis by the National Conference of State Legislatures shows similar bills in at least 35 other states. Laws already are in place in at least 13 states.

Some pharmacies are currently stifled from divulging information on medication affordability due to so-called gag clauses put in place by pharmaceutical benefit managers.

The middleman commercial groups say they negotiate optimal drug costs between the original manufacturer and the consumer. They have recently been criticized by insurers and consumers for boxing patients into paying more under their insurance plan than they would have out-of-pocket.

 

Recent Posts

Stay in the Know

Get the latest news and updates on issues impacting the long-term pharmacy community.

See Latest Updates